Navigation Links
Stent for life initiative
Date:9/1/2009

Barcelona, Spain, 1 September: Primary angioplasty (with stent implantation) is the most effective therapy for acute myocardial infarction (AMI), but it is not available to many patients, even though most European countries have sufficient resources (ie, catheterisation laboratories) for its wider use. The Stents 4 Life initiative was a study aiming to analyze the use of primary angioplasty in the treatment of AMI in 27 European countries.

Data were collected from national infarction or angioplasty registries, on AMI epidemiology and treatment and on angioplasty centres and procedures in each country.

Findings showed that the frequency (annual incidence) of hospital admission for any AMI varied between 90 and 312 events per 100,000 population per year; the incidence of serious AMIs (with ST-elevations on ECG - STEMI) ranging from 44-142 per thousand.

Primary angioplasty (primary PCI) was the dominant reperfusion strategy in 17 countries and thrombolysis in nine countries. The application of a PCI strategy varied between 5 and 92% (in all STEMI patients), and use of thrombolysis (an older, less effective form of therapy) between 0 and 55%. Curent guidelines recopmmend that any reperfusion treatment (angioplasty or thrombolysis) should be used ideally in 100% of these patients; however, we found it used only in 37󈟉% of STEMI patients.

The number of primary angioplasty procedures per million population per year varied among countries between 20 and 970. The mean population served by a single primary angioplasty centre varied between 0.3 and 7.4 million inhabitants. In those coutries offering primary angioplasty services to most of their STEMI patients, population varied between 0.3 and 1.1 million per centre.

In-hospital mortality of all consecutive STEMI patients varied between 4.2 and 13.5%, of patients treated by thrombolysis between 3.5 and 14%, and of patients treated by primary PCI between 2.7 and 8%.<
'/>"/>

Contact: Jacquelline Partarrieu
jpartarrieu@escardio.org
0034-600-919-617
European Society of Cardiology
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
2. Adding a Stent May Help Resolve Brain Aneurysm
3. Health Canada Approves Abbotts XIENCE V(R) Drug Eluting Stent
4. Stenting a Good Option for Left Main Heart Artery
5. Stent Studies Tied to Rapid Changes in Use
6. QHR Client Hospitals Lauded for Consistently High Quality Standards, Exceeding Patient Expectations
7. FDA Approves Boston Scientifics TAXUS(R) Liberte(R) Long Stent
8. AbbeyMoor Medical Receives FDA Approval for Design Improvements to The Spanner(TM) Prostatic Stent
9. CorNova(R) Receives CE Mark Approval for Valecor Platinum(R) Coronary Stent System
10. Abbott Receives CE Mark for Companys Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position
11. Newest Coated Stent Does Well in Real-World Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... May 19, 2013 Daily Gossip reporters have ... 17 Cheat Foods That Burn Fat to a close ... , The review is a detailed explanation ... the writer's recommendation. , The two nutritionists have discovered during ... responsible for the caloric intake and expenditure of our body, ...
(Date:5/19/2013)... Doheny HealthDay Reporter , , SATURDAY, May ... help those with Crohn,s disease overcome the fatigue ... bowel disease, according to new research. Extra ... emotional and general fatigue, greater quality of life ... living," said Tara Raftery, a research dietitian and ...
(Date:5/19/2013)... 2013 People in Minnesota have a great ... is offering its 28 Day Fat Loss Formula. The ... comfort of their own home. The product sells for $135 ... can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season ... houses now, but after using the 28 Day Fat Loss ...
(Date:5/19/2013)... Angeles, California (PRWEB) May 19, 2013 ... damage than just losing sleep, or annoying your spouse. ... 2013 report by CNY Central (“Snoring and Teeth Grinding ... certain type of teeth grinding can be hard to ... 12 million Americans, and one of its symptoms is ...
(Date:5/19/2013)... 19, 2013 Fat Burning Furnace developed ... that provides people with fat burning diet ... this Fat Burning Furnace package, people will receive the ... can download quickly. The Fat Burning Furnace manual includes ... build lean muscle mass. In addition, this book covers ...
Breaking Medicine News(10 mins):Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2
... a life of dignity with access to medicines and ... diseases like cancer, say experts on the eve of ... few states like Kerala, Maharashtra, Karnataka and Orissa as ... care-giving organizations to administer strong painkillers that make life ...
... cervical vaccine developed by Sanofi Pasteur and Merck and ... is given in three doses over 6 months which has shown ... this year. The vaccine protects against Human Papilloma virus infection and ... vaccines may hit the market early next year and the profits ...
... from Southampton University have found a new gene based test ... more genes fuse. The research team is focusing on detection ... childhood leukemia, which is called as Acute Lymphoblastic Leukemia (ALL). ... genetic test. The treatment is given by chemotherapy which kills ...
... the EPFL (Ecole Polytechnique Federale de Lausanne) and the ... in the hair follicle belong to the true multipotent ... cell types needed for hair growth and follicle replacement. ... in an advance online publication of the October 3 ...
... A new study appearing in the October issue of the ... milk is more than that of Cow's milk. , ... in New York and her colleague Dr. William H. Bowen ... to cause tooth decay faster than cow's milk. Baby mice ...
... of Multiple Sclerosis (MS), has been withdrawn from market after ... The relationship between the drug and // Progressive Multifocal Leukoencephalopathy ... is deemed to pose a significant risk, it could be ... work by blocking passage of immune cells in to the ...
Cached Medicine News:Health News:Terminally Ill Patients Could Be Offered A Better Life 2Health News:Gardasil vaccine for cervical cancer 2
(Date:5/17/2013)... 2013 Medical devices are any medical items ... In light of their different mechanisms, actions and regulatory ... complicated than drug trails due to their unique clinical ... of evaluating both safety and efficacy (which is left ... the same as the SFDA) evaluate MDs for both ...
(Date:5/17/2013)... 2013  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or ... Small Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) ... Diseases (NIAID), a division of the National Institutes ... human antibody therapeutics to combat Staphylococcus aureus ... including methicillin-resistant S. aureus (MRSA), was ...
(Date:5/17/2013)... 17, 2013  Technology advances have had a ... with a constantly evolving communication environment, companies need ... communicating with internal executives. It is challenging, however, ... tactics and tools that are part of today,s ... study, Best Practices, LLC explores the various internal ...
Breaking Medicine Technology:Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2
... , , SALT LAKE CITY, Dec. 4 ... signed a sole-source vendor agreement to provide therapy equipment and ... in Tennessee and Georgia. , "We are pleased to ... Larry K. Beardall, executive vice president of sales and marketing ...
... Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), ... threats, announced today the presentation of new data from the ... Antigen (rPA) based anthrax vaccine is structurally stable and potent ... 55 degrees C. The data were presented by Dr. ...
Cached Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5
... motility testing simpler than ever ... up in seconds and protect ... sensor circumferential, Air-Charged Catheters improve ... For advanced performance made easy, ...
... single-use products to promote safety for your ... catheter reduces cross-contamination and helps protect your ... because cleaning is eliminated, you have more ... water perfused manometric catheters for esophageal, anorectal ...
Anorectal Stylet for LATITUDE® Air-Charged Catheter...
Polygraf ID Adapter Cable for LATITUDE® Air-Charged Catheter...
Medicine Products: